Treatment with CUDC-907 effectively suppressed proliferation and induced apoptosis in ATLL cell lines and primary HTLV-1-infected cells by simultaneously disrupting PI3K/AKT survival signaling and altering the epigenetic regulation of gene expression [72]. Here, AKT1 is linked to adult T-cell leukemia/lymphoma.